A Study Comparing the Efficacy and Safety of Etrolizumab With Adalimumab and Placebo in Participants With Moderate to Severe Ulcerative Colitis (UC) in Participants Naive to Tumor Necrosis Factor (TNF) Inhibitors
Clinical trial NCT02171429 · COMPLETED
Trial details
- NCT number
- NCT02171429
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-11-14
- Primary completion
- 2020-03-02
- Enrollment
- 358
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.